Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BGXX |
---|---|---|
09:32 ET | 1670 | 0.2571 |
09:34 ET | 47886 | 0.2571 |
09:36 ET | 5000 | 0.256001 |
09:38 ET | 936 | 0.2585 |
09:39 ET | 18480 | 0.258399 |
09:41 ET | 15463 | 0.256 |
09:43 ET | 1078 | 0.2585 |
09:45 ET | 4637 | 0.2585 |
09:50 ET | 420 | 0.2559 |
09:52 ET | 1962 | 0.257899 |
09:54 ET | 300 | 0.258 |
09:57 ET | 200 | 0.256 |
09:59 ET | 1300 | 0.2569 |
10:01 ET | 22688 | 0.258 |
10:03 ET | 2534 | 0.258 |
10:06 ET | 4461 | 0.258 |
10:08 ET | 400 | 0.2501 |
10:10 ET | 6500 | 0.2501 |
10:12 ET | 1600 | 0.258 |
10:14 ET | 1282 | 0.254685 |
10:15 ET | 11417 | 0.252399 |
10:21 ET | 1000 | 0.2513 |
10:24 ET | 36259 | 0.25 |
10:26 ET | 247 | 0.25 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bright Green Corp | 47.9M | -4.6x | --- |
Eyenovia Inc | 46.7M | -1.5x | --- |
Odonate Inc | 49.6M | -1,247.4x | --- |
Lexaria Bioscience Corp | 47.0M | -4.5x | --- |
Vyne Therapeutics Inc | 41.7M | -0.5x | --- |
Aptorum Group Ltd | 45.1M | -2.5x | --- |
Bright Green Corporation is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and as an active ingredient to consumer-based solutions. The Company is engaged in cannabis propagation, cultivation, and manufacturing of cannabis products, including cannabis flower, pre-rolls, concentrates, vape pens, capsules, tinctures, edibles, topicals and any other cannabis-related products requested for authorized sales. The Company plans to sell extracted oils from medicinal plants grown in these high-tech facilities and processed onsite through a system that vertically integrates the genetically altered growth of the plants to conform to automated growing systems. It also plans to cultivate and manufacture cannabis for federally sanctioned research, as well as perform authorized research on cannabis, including cannabinol (CBN), cannabigerol (CBG), and cannabidiol (CBD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 186.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.05 |
Book Value | $0.07 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.